Vizag Study Shows High Dengue, Chikungunya Seroprevalence
A Vizag study finds over 90% dengue immunity, 60% for chikungunya, yet few active cases. Learn how serosurveys uncover hidden endemic transmission.
Category : Search result: seroprevalence
Page 1 of 1